Earnout
Contingent payment mechanism tying part of the acquisition price to the target's future financial performance.
FAQs
When do earnouts make sense in an acquisition?
Earnouts make sense when there is a significant valuation gap between buyer and seller that cannot be bridged through negotiation alone, when the business's future performance is highly uncertain (new product launches, regulatory pending approvals, key customer relationships dependent on the seller), or when retaining the seller post-closing is important for business continuity. They are less appropriate in mature businesses with predictable financials where earnout disputes would outweigh the transaction benefits, or when the buyer will significantly integrate the acquisition, making attribution of earnout results to the target impossible.
How are earnout payments treated for tax purposes?
Earnout tax treatment depends on how the payments are structured. If earnouts are purely contingent purchase price (tied to business performance, not seller employment), they are taxed as additional capital gain recognized when the contingency is resolved or when the amounts are determinable. If earnouts require the seller to remain employed, the IRS may recharacterize payments as compensation income subject to ordinary income rates and payroll taxes. The seller generally prefers capital gains treatment; buyers often prefer compensation treatment (which is deductible). This tension drives significant earnout structuring negotiations.
What earnout metrics are most commonly used?
Revenue is the most common earnout metric because it is relatively objective and difficult for the buyer to manipulate. EBITDA is used when profitability is the key uncertainty but requires careful definition of allocated costs to prevent buyer manipulation through overhead allocation. Gross profit is a middle ground that captures revenue quality without full cost allocation complexity. Non-financial metrics—regulatory approvals, product launches, clinical trial milestones, customer wins—are preferred in life sciences and technology acquisitions where financial performance depends on specific future events rather than ongoing business operations.
Related Terms
Letter of Intent
Preliminary document expressing a party's intent to enter a transaction, outlining key proposed terms.
Representations and Warranties
Contractual statements of fact in a purchase agreement that allocate risk between buyer and seller.
Indemnification
Contractual obligation by one party to compensate another for losses arising from specified events or breaches.
Term Sheet
Non-binding document outlining the key terms of a proposed investment or acquisition deal.